Predict thrombocytopenia at the preclinical drug development stage.
These in vitro assays replicate in vivo cell biology conditions. We incubate primary bone marrow cells with your test compounds in a collagen-based matrix containing specific growth factors. We then fix and stain the cultures for CD41, count the colonies, and provide you with a detailed report on your drug’s off-target toxicity impact.
The preclinical screening method that helps clients eliminate bad players earlier in the drug development process. Whitepaper
A quick reference resource for scientists who need to isolate, manipulate, or develop assays involving human mononuclear cells. Video
